The Pneumococcal vaccines Accelerated Development and Introduction Plan is based at Johns Hopkins Bloomberg School of Public Health and is funded by GAVI Alliance.

PneumoADIP is based at Johns Hopkins Bloomberg School of Public Health and is funded by GAVI Alliance

Vaccine Alliance, GAVI, Johns Hopkins Bloomberg School of Public Health, WHO.

About Us

The PneumoADIP Mission:

To improve child survival and health by accelerating the evaluation of and access to new, lifesaving pneumococcal vaccines for the world's children.

PneumoADIP is a small, dedicated team based at Johns Hopkins Bloomberg School of Public Health and is supported by a $30 million grant from the Global Alliance for Vaccines and Immunization. PneumoADIP aims to achieve its goals through partnerships with countries, donors, academia, international organizations and industry. PneumoADIP coordinates its activities through a strategic alliance with the World Health Organization.